Strategic partnerships Ethypharm has global reach in 68 countries with strategic partnerships across EMEA, NA, LATAM and APAC, presenting recurring cross-border collaboration opportunities for licensing, co-marketing, and distribution expansion.

Hospital injectables focus Specialization in hospital injectables and CNS therapies positions Ethypharm as a partner for hospitals and specialty distributors seeking reliable supply of high-complexity injectables and pain/addiction treatments.

Growth through leadership Recent leadership appointments in Human Resources and Commercial leadership indicate a push to scale operations and accelerate market expansion, signaling receptiveness to new commercial and channel partnerships.

Strategic collaborations Partnerships with entities in medical cannabis, infant healthcare, and selective antithrombin agents show appetite for diversified collaborations and potential for portfolio expansion through licensing or co-development.

Emerging markets access Six production sites across France, the UK, Spain, and China plus global sales footprint create entry points for regional supply agreements, OEM-like manufacturing partnerships, and regional market access initiatives.